Zobrazeno 1 - 10 of 56 pro vyhledávání: '"Pairet, G."'
1
Akademický článek
The Role of c-MET as a Biomarker in Patients with Bladder Cancer Treated with Radical Chemo-Radiotherapy.
Autor: Houssiau H; Department of Medical Oncology, Groupe Jolimont, 7100 Haine Saint Paul, Belgium., Pairet G; Department of Pathology, Groupe Jolimont, 7100 Haine Saint Paul, Belgium., Dano H; Department of Pathology, Cliniques Universitaires Saint Luc, 1200 Brussels, Belgium., Seront E; Department of Medical Oncology, Groupe Jolimont, 7100 Haine Saint Paul, Belgium.
Publikováno v: Current oncology (Toronto, Ont.) [Curr Oncol] 2023 Dec 18; Vol. 30 (12), pp. 10550-10555. Date of Electronic Publication: 2023 Dec 18.
Zobrazit plný text záznamu
2
Report
Highlighting the Place of Metastasis-Directed Therapy in Isolated Liver Metastases in Prostate Cancer: A Case Report.
Autor: Yeo AE; Department of Medical Oncology, Jolimont Hospital, La Louvière, Belgium., Hendrix A; Department of Medical Oncology, Jolimont Hospital, La Louvière, Belgium., Confente C; Department of Medical Oncology, Jolimont Hospital, La Louvière, Belgium., Christian N; Department of Radiotherapy, Jolimont Hospital, La Louvière, Belgium., Mansvelt B; Department of Surgery, Jolimont Hospital, La Louvière, Belgium., Pairet G; Department of Pathology, Jolimont Hospital, La Louvière, Belgium., Seront E; Department of Medical Oncology, Jolimont Hospital, La Louvière, Belgium.
Publikováno v: Frontiers in oncology [Front Oncol] 2021 Nov 17; Vol. 11, pp. 764758. Date of Electronic Publication: 2021 Nov 17 (Print Publication: 2021).
Zobrazit plný text záznamu
3
Report
Isolated peritoneal carcinomatosis in prostate cancer: from a successful hormonal management to a review of the literature.
Autor: Delchambre E; Department of Urology, Hôpital de Jolimont, Haine Saint-Paul,7100, Belgium., Rysselinck S; Department of Urology, Hôpital de Jolimont, Haine Saint-Paul,7100, Belgium., Pairet G; Department of Pathology, Hôpital de Jolimont, Haine Saint-Paul, 7100, Belgium., Confente C; Department of Medical Oncology, Hôpital de Jolimont, Haine Saint-Paul, 7100, Belgium., Seront E; Department of Medical Oncology, Hôpital de Jolimont, Haine Saint-Paul, 7100, Belgium.
Publikováno v: Future science OA [Future Sci OA] 2021 Apr 30; Vol. 7 (6), pp. FSO707. Date of Electronic Publication: 2021 Apr 30.
Zobrazit plný text záznamu
4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
5
Report
Case Reports in Oncological Medicine Myoepithelioma: A New Rearrangement Involving the LPP Locus in a Case of Multiple Bone and Soft Tissue Lesions.
Autor: Pairet G; Department of Pathology, Cliniques Universitaires Saint-Luc, Brussels, Belgium., Tilman G; Center for Human Genetics, Cliniques Universitaires Saint-Luc-Université catholique de Louvain, Brussels, Belgium., Sciot R; Department of Pathology, Katholieke Universiteit Leuven, Leuven, Belgium., Schubert T; Department of Orthopaedic Surgery, Cliniques Universitaires Saint-Luc, Brussels, Belgium., Perlepe V; Department of Medical Imaging, Cliniques Universitaires St-Luc, Brussels, Belgium., Poirel HA; Center for Human Genetics, Cliniques Universitaires Saint-Luc and Human Molecular Genetics, de Duve Institute, Université catholique de Louvain, Brussels, Belgium., Galant C; Department of Pathology, Cliniques Universitaires St-Luc and IREC, Pôle de morphologie MORF, Université Catholique de Louvain, Brussels, Belgium.
Publikováno v: Case reports in oncological medicine [Case Rep Oncol Med] 2018 Feb 27; Vol. 2018, pp. 3512847. Date of Electronic Publication: 2018 Feb 27 (Print Publication: 2018).
Zobrazit plný text záznamu
6
Akademický článek
Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on Survival.
Autor: Mlecnik B; Laboratory of Integrative Cancer Immunology, INSERM, UMRS1138, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, UMRS1138, Paris, France; Sorbonne Universités, UPMC Univ Paris 06, UMRS1138, Centre de Recherche des Cordeliers, Paris, France; Inovarion, Paris, France; Department of Medical Oncology, Cliniques Universitaires St-Luc and Institut de Recherche Clinique et Experimentale (Pole MIRO), Institut Roi Albert II, Université Catholique de Louvain, Brussels, Belgium; Department of Immunology, HEGP, Assistance Publique-Hopitaux de Paris, Paris, France; AstraZeneca, Cambridge, UK; Departments of General and Digestive Surgery, HEGP, AP-HP, Assistance Publique-Hopitaux de Paris, Paris, France; Grand Hopital de Charleroi, Charleroi, Belgium., Van den Eynde M; Laboratory of Integrative Cancer Immunology, INSERM, UMRS1138, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, UMRS1138, Paris, France; Sorbonne Universités, UPMC Univ Paris 06, UMRS1138, Centre de Recherche des Cordeliers, Paris, France; Inovarion, Paris, France; Department of Medical Oncology, Cliniques Universitaires St-Luc and Institut de Recherche Clinique et Experimentale (Pole MIRO), Institut Roi Albert II, Université Catholique de Louvain, Brussels, Belgium; Department of Immunology, HEGP, Assistance Publique-Hopitaux de Paris, Paris, France; AstraZeneca, Cambridge, UK; Departments of General and Digestive Surgery, HEGP, AP-HP, Assistance Publique-Hopitaux de Paris, Paris, France; Grand Hopital de Charleroi, Charleroi, Belgium., Bindea G; Laboratory of Integrative Cancer Immunology, INSERM, UMRS1138, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, UMRS1138, Paris, France; Sorbonne Universités, UPMC Univ Paris 06, UMRS1138, Centre de Recherche des Cordeliers, Paris, France; Inovarion, Paris, France; Department of Medical Oncology, Cliniques Universitaires St-Luc and Institut de Recherche Clinique et Experimentale (Pole MIRO), Institut Roi Albert II, Université Catholique de Louvain, Brussels, Belgium; Department of Immunology, HEGP, Assistance Publique-Hopitaux de Paris, Paris, France; AstraZeneca, Cambridge, UK; Departments of General and Digestive Surgery, HEGP, AP-HP, Assistance Publique-Hopitaux de Paris, Paris, France; Grand Hopital de Charleroi, Charleroi, Belgium., Church SE; Laboratory of Integrative Cancer Immunology, INSERM, UMRS1138, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, UMRS1138, Paris, France; Sorbonne Universités, UPMC Univ Paris 06, UMRS1138, Centre de Recherche des Cordeliers, Paris, France; Inovarion, Paris, France; Department of Medical Oncology, Cliniques Universitaires St-Luc and Institut de Recherche Clinique et Experimentale (Pole MIRO), Institut Roi Albert II, Université Catholique de Louvain, Brussels, Belgium; Department of Immunology, HEGP, Assistance Publique-Hopitaux de Paris, Paris, France; AstraZeneca, Cambridge, UK; Departments of General and Digestive Surgery, HEGP, AP-HP, Assistance Publique-Hopitaux de Paris, Paris, France; Grand Hopital de Charleroi, Charleroi, Belgium., Vasaturo A; Laboratory of Integrative Cancer Immunology, INSERM, UMRS1138, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, UMRS1138, Paris, France; Sorbonne Universités, UPMC Univ Paris 06, UMRS1138, Centre de Recherche des Cordeliers, Paris, France; Inovarion, Paris, France; Department of Medical Oncology, Cliniques Universitaires St-Luc and Institut de Recherche Clinique et Experimentale (Pole MIRO), Institut Roi Albert II, Université Catholique de Louvain, Brussels, Belgium; Department of Immunology, HEGP, Assistance Publique-Hopitaux de Paris, Paris, France; AstraZeneca, Cambridge, UK; Departments of General and Digestive Surgery, HEGP, AP-HP, Assistance Publique-Hopitaux de Paris, Paris, France; Grand Hopital de Charleroi, Charleroi, Belgium., Fredriksen T; Laboratory of Integrative Cancer Immunology, INSERM, UMRS1138, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, UMRS1138, Paris, France; Sorbonne Universités, UPMC Univ Paris 06, UMRS1138, Centre de Recherche des Cordeliers, Paris, France; Inovarion, Paris, France; Department of Medical Oncology, Cliniques Universitaires St-Luc and Institut de Recherche Clinique et Experimentale (Pole MIRO), Institut Roi Albert II, Université Catholique de Louvain, Brussels, Belgium; Department of Immunology, HEGP, Assistance Publique-Hopitaux de Paris, Paris, France; AstraZeneca, Cambridge, UK; Departments of General and Digestive Surgery, HEGP, AP-HP, Assistance Publique-Hopitaux de Paris, Paris, France; Grand Hopital de Charleroi, Charleroi, Belgium., Lafontaine L; Laboratory of Integrative Cancer Immunology, INSERM, UMRS1138, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, UMRS1138, Paris, France; Sorbonne Universités, UPMC Univ Paris 06, UMRS1138, Centre de Recherche des Cordeliers, Paris, France; Inovarion, Paris, France; Department of Medical Oncology, Cliniques Universitaires St-Luc and Institut de Recherche Clinique et Experimentale (Pole MIRO), Institut Roi Albert II, Université Catholique de Louvain, Brussels, Belgium; Department of Immunology, HEGP, Assistance Publique-Hopitaux de Paris, Paris, France; AstraZeneca, Cambridge, UK; Departments of General and Digestive Surgery, HEGP, AP-HP, Assistance Publique-Hopitaux de Paris, Paris, France; Grand Hopital de Charleroi, Charleroi, Belgium., Haicheur N; Laboratory of Integrative Cancer Immunology, INSERM, UMRS1138, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, UMRS1138, Paris, France; Sorbonne Universités, UPMC Univ Paris 06, UMRS1138, Centre de Recherche des Cordeliers, Paris, France; Inovarion, Paris, France; Department of Medical Oncology, Cliniques Universitaires St-Luc and Institut de Recherche Clinique et Experimentale (Pole MIRO), Institut Roi Albert II, Université Catholique de Louvain, Brussels, Belgium; Department of Immunology, HEGP, Assistance Publique-Hopitaux de Paris, Paris, France; AstraZeneca, Cambridge, UK; Departments of General and Digestive Surgery, HEGP, AP-HP, Assistance Publique-Hopitaux de Paris, Paris, France; Grand Hopital de Charleroi, Charleroi, Belgium., Marliot F; Laboratory of Integrative Cancer Immunology, INSERM, UMRS1138, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, UMRS1138, Paris, France; Sorbonne Universités, UPMC Univ Paris 06, UMRS1138, Centre de Recherche des Cordeliers, Paris, France; Inovarion, Paris, France; Department of Medical Oncology, Cliniques Universitaires St-Luc and Institut de Recherche Clinique et Experimentale (Pole MIRO), Institut Roi Albert II, Université Catholique de Louvain, Brussels, Belgium; Department of Immunology, HEGP, Assistance Publique-Hopitaux de Paris, Paris, France; AstraZeneca, Cambridge, UK; Departments of General and Digestive Surgery, HEGP, AP-HP, Assistance Publique-Hopitaux de Paris, Paris, France; Grand Hopital de Charleroi, Charleroi, Belgium., Debetancourt D; Laboratory of Integrative Cancer Immunology, INSERM, UMRS1138, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, UMRS1138, Paris, France; Sorbonne Universités, UPMC Univ Paris 06, UMRS1138, Centre de Recherche des Cordeliers, Paris, France; Inovarion, Paris, France; Department of Medical Oncology, Cliniques Universitaires St-Luc and Institut de Recherche Clinique et Experimentale (Pole MIRO), Institut Roi Albert II, Université Catholique de Louvain, Brussels, Belgium; Department of Immunology, HEGP, Assistance Publique-Hopitaux de Paris, Paris, France; AstraZeneca, Cambridge, UK; Departments of General and Digestive Surgery, HEGP, AP-HP, Assistance Publique-Hopitaux de Paris, Paris, France; Grand Hopital de Charleroi, Charleroi, Belgium., Pairet G; Laboratory of Integrative Cancer Immunology, INSERM, UMRS1138, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, UMRS1138, Paris, France; Sorbonne Universités, UPMC Univ Paris 06, UMRS1138, Centre de Recherche des Cordeliers, Paris, France; Inovarion, Paris, France; Department of Medical Oncology, Cliniques Universitaires St-Luc and Institut de Recherche Clinique et Experimentale (Pole MIRO), Institut Roi Albert II, Université Catholique de Louvain, Brussels, Belgium; Department of Immunology, HEGP, Assistance Publique-Hopitaux de Paris, Paris, France; AstraZeneca, Cambridge, UK; Departments of General and Digestive Surgery, HEGP, AP-HP, Assistance Publique-Hopitaux de Paris, Paris, France; Grand Hopital de Charleroi, Charleroi, Belgium., Jouret-Mourin A; Laboratory of Integrative Cancer Immunology, INSERM, UMRS1138, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, UMRS1138, Paris, France; Sorbonne Universités, UPMC Univ Paris 06, UMRS1138, Centre de Recherche des Cordeliers, Paris, France; Inovarion, Paris, France; Department of Medical Oncology, Cliniques Universitaires St-Luc and Institut de Recherche Clinique et Experimentale (Pole MIRO), Institut Roi Albert II, Université Catholique de Louvain, Brussels, Belgium; Department of Immunology, HEGP, Assistance Publique-Hopitaux de Paris, Paris, France; AstraZeneca, Cambridge, UK; Departments of General and Digestive Surgery, HEGP, AP-HP, Assistance Publique-Hopitaux de Paris, Paris, France; Grand Hopital de Charleroi, Charleroi, Belgium., Gigot JF; Laboratory of Integrative Cancer Immunology, INSERM, UMRS1138, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, UMRS1138, Paris, France; Sorbonne Universités, UPMC Univ Paris 06, UMRS1138, Centre de Recherche des Cordeliers, Paris, France; Inovarion, Paris, France; Department of Medical Oncology, Cliniques Universitaires St-Luc and Institut de Recherche Clinique et Experimentale (Pole MIRO), Institut Roi Albert II, Université Catholique de Louvain, Brussels, Belgium; Department of Immunology, HEGP, Assistance Publique-Hopitaux de Paris, Paris, France; AstraZeneca, Cambridge, UK; Departments of General and Digestive Surgery, HEGP, AP-HP, Assistance Publique-Hopitaux de Paris, Paris, France; Grand Hopital de Charleroi, Charleroi, Belgium., Hubert C; Laboratory of Integrative Cancer Immunology, INSERM, UMRS1138, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, UMRS1138, Paris, France; Sorbonne Universités, UPMC Univ Paris 06, UMRS1138, Centre de Recherche des Cordeliers, Paris, France; Inovarion, Paris, France; Department of Medical Oncology, Cliniques Universitaires St-Luc and Institut de Recherche Clinique et Experimentale (Pole MIRO), Institut Roi Albert II, Université Catholique de Louvain, Brussels, Belgium; Department of Immunology, HEGP, Assistance Publique-Hopitaux de Paris, Paris, France; AstraZeneca, Cambridge, UK; Departments of General and Digestive Surgery, HEGP, AP-HP, Assistance Publique-Hopitaux de Paris, Paris, France; Grand Hopital de Charleroi, Charleroi, Belgium., Danse E; Laboratory of Integrative Cancer Immunology, INSERM, UMRS1138, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, UMRS1138, Paris, France; Sorbonne Universités, UPMC Univ Paris 06, UMRS1138, Centre de Recherche des Cordeliers, Paris, France; Inovarion, Paris, France; Department of Medical Oncology, Cliniques Universitaires St-Luc and Institut de Recherche Clinique et Experimentale (Pole MIRO), Institut Roi Albert II, Université Catholique de Louvain, Brussels, Belgium; Department of Immunology, HEGP, Assistance Publique-Hopitaux de Paris, Paris, France; AstraZeneca, Cambridge, UK; Departments of General and Digestive Surgery, HEGP, AP-HP, Assistance Publique-Hopitaux de Paris, Paris, France; Grand Hopital de Charleroi, Charleroi, Belgium., Dragean C; Laboratory of Integrative Cancer Immunology, INSERM, UMRS1138, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, UMRS1138, Paris, France; Sorbonne Universités, UPMC Univ Paris 06, UMRS1138, Centre de Recherche des Cordeliers, Paris, France; Inovarion, Paris, France; Department of Medical Oncology, Cliniques Universitaires St-Luc and Institut de Recherche Clinique et Experimentale (Pole MIRO), Institut Roi Albert II, Université Catholique de Louvain, Brussels, Belgium; Department of Immunology, HEGP, Assistance Publique-Hopitaux de Paris, Paris, France; AstraZeneca, Cambridge, UK; Departments of General and Digestive Surgery, HEGP, AP-HP, Assistance Publique-Hopitaux de Paris, Paris, France; Grand Hopital de Charleroi, Charleroi, Belgium., Carrasco J; Laboratory of Integrative Cancer Immunology, INSERM, UMRS1138, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, UMRS1138, Paris, France; Sorbonne Universités, UPMC Univ Paris 06, UMRS1138, Centre de Recherche des Cordeliers, Paris, France; Inovarion, Paris, France; Department of Medical Oncology, Cliniques Universitaires St-Luc and Institut de Recherche Clinique et Experimentale (Pole MIRO), Institut Roi Albert II, Université Catholique de Louvain, Brussels, Belgium; Department of Immunology, HEGP, Assistance Publique-Hopitaux de Paris, Paris, France; AstraZeneca, Cambridge, UK; Departments of General and Digestive Surgery, HEGP, AP-HP, Assistance Publique-Hopitaux de Paris, Paris, France; Grand Hopital de Charleroi, Charleroi, Belgium., Humblet Y; Laboratory of Integrative Cancer Immunology, INSERM, UMRS1138, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, UMRS1138, Paris, France; Sorbonne Universités, UPMC Univ Paris 06, UMRS1138, Centre de Recherche des Cordeliers, Paris, France; Inovarion, Paris, France; Department of Medical Oncology, Cliniques Universitaires St-Luc and Institut de Recherche Clinique et Experimentale (Pole MIRO), Institut Roi Albert II, Université Catholique de Louvain, Brussels, Belgium; Department of Immunology, HEGP, Assistance Publique-Hopitaux de Paris, Paris, France; AstraZeneca, Cambridge, UK; Departments of General and Digestive Surgery, HEGP, AP-HP, Assistance Publique-Hopitaux de Paris, Paris, France; Grand Hopital de Charleroi, Charleroi, Belgium., Valge-Archer V; Laboratory of Integrative Cancer Immunology, INSERM, UMRS1138, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, UMRS1138, Paris, France; Sorbonne Universités, UPMC Univ Paris 06, UMRS1138, Centre de Recherche des Cordeliers, Paris, France; Inovarion, Paris, France; Department of Medical Oncology, Cliniques Universitaires St-Luc and Institut de Recherche Clinique et Experimentale (Pole MIRO), Institut Roi Albert II, Université Catholique de Louvain, Brussels, Belgium; Department of Immunology, HEGP, Assistance Publique-Hopitaux de Paris, Paris, France; AstraZeneca, Cambridge, UK; Departments of General and Digestive Surgery, HEGP, AP-HP, Assistance Publique-Hopitaux de Paris, Paris, France; Grand Hopital de Charleroi, Charleroi, Belgium., Berger A; Laboratory of Integrative Cancer Immunology, INSERM, UMRS1138, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, UMRS1138, Paris, France; Sorbonne Universités, UPMC Univ Paris 06, UMRS1138, Centre de Recherche des Cordeliers, Paris, France; Inovarion, Paris, France; Department of Medical Oncology, Cliniques Universitaires St-Luc and Institut de Recherche Clinique et Experimentale (Pole MIRO), Institut Roi Albert II, Université Catholique de Louvain, Brussels, Belgium; Department of Immunology, HEGP, Assistance Publique-Hopitaux de Paris, Paris, France; AstraZeneca, Cambridge, UK; Departments of General and Digestive Surgery, HEGP, AP-HP, Assistance Publique-Hopitaux de Paris, Paris, France; Grand Hopital de Charleroi, Charleroi, Belgium., Pagès F; Laboratory of Integrative Cancer Immunology, INSERM, UMRS1138, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, UMRS1138, Paris, France; Sorbonne Universités, UPMC Univ Paris 06, UMRS1138, Centre de Recherche des Cordeliers, Paris, France; Inovarion, Paris, France; Department of Medical Oncology, Cliniques Universitaires St-Luc and Institut de Recherche Clinique et Experimentale (Pole MIRO), Institut Roi Albert II, Université Catholique de Louvain, Brussels, Belgium; Department of Immunology, HEGP, Assistance Publique-Hopitaux de Paris, Paris, France; AstraZeneca, Cambridge, UK; Departments of General and Digestive Surgery, HEGP, AP-HP, Assistance Publique-Hopitaux de Paris, Paris, France; Grand Hopital de Charleroi, Charleroi, Belgium., Machiels JP; Laboratory of Integrative Cancer Immunology, INSERM, UMRS1138, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, UMRS1138, Paris, France; Sorbonne Universités, UPMC Univ Paris 06, UMRS1138, Centre de Recherche des Cordeliers, Paris, France; Inovarion, Paris, France; Department of Medical Oncology, Cliniques Universitaires St-Luc and Institut de Recherche Clinique et Experimentale (Pole MIRO), Institut Roi Albert II, Université Catholique de Louvain, Brussels, Belgium; Department of Immunology, HEGP, Assistance Publique-Hopitaux de Paris, Paris, France; AstraZeneca, Cambridge, UK; Departments of General and Digestive Surgery, HEGP, AP-HP, Assistance Publique-Hopitaux de Paris, Paris, France; Grand Hopital de Charleroi, Charleroi, Belgium., Galon J; Laboratory of Integrative Cancer Immunology, INSERM, UMRS1138, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, UMRS1138, Paris, France; Sorbonne Universités, UPMC Univ Paris 06, UMRS1138, Centre de Recherche des Cordeliers, Paris, France; Inovarion, Paris, France; Department of Medical Oncology, Cliniques Universitaires St-Luc and Institut de Recherche Clinique et Experimentale (Pole MIRO), Institut Roi Albert II, Université Catholique de Louvain, Brussels, Belgium; Department of Immunology, HEGP, Assistance Publique-Hopitaux de Paris, Paris, France; AstraZeneca, Cambridge, UK; Departments of General and Digestive Surgery, HEGP, AP-HP, Assistance Publique-Hopitaux de Paris, Paris, France; Grand Hopital de Charleroi, Charleroi, Belgium.
Publikováno v: Journal of the National Cancer Institute [J Natl Cancer Inst] 2018 Jan 01; Vol. 110 (1).
Zobrazit plný text záznamu
7
Akademický článek
Prostate Cancer Liver Metastasis: An Ominous Metastatic Site in Need of Distinct Management Strategies.
Autor: Shiner, Audrey1,2,3 (AUTHOR) audrey.shiner@sri.utoronto.ca, Sperandio, Rubens Copia1,4 (AUTHOR) rubens.copiasperandio@sunnybrook.ca, Naimi, Mahdi1,2 (AUTHOR) mahdi.naimi@sri.utoronto.ca, Emmenegger, Urban1,2,3,4 (AUTHOR) uemmengg@sri.utoronto.ca
Publikováno v: Journal of Clinical Medicine. Feb2024, Vol. 13 Issue 3, p734. 13p.
Zobrazit plný text záznamu
9
Akademický článek
Clinicopathological significance of c-MET and HER2 altered expression in bladder cancer.
Autor: Naguib, Engy Mohammed, Ismail, EF, Badran, DI, Sherief, MH, El-Abaseri, TB
Publikováno v: Journal of the Egyptian National Cancer Institute; 12/26/2024, Vol. 36 Issue 1, p1-9, 9p
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje